GSTS Nominated for HealthInvestor Award

Thursday 17, February 2011

GSTS Pathology has been recognised for making an outstanding contribution to the healthcare industry in 2010 by being nominated for a HealthInvestor Award in the 'Diagnostics Provider of the Year' category.

The HealthInvestor Awards recognise excellence and innovation in the healthcare sector and will be judged by a panel of experts from across the public and private healthcare spectrum.

The nomination acknowledges GSTS' vision of providing the highest quality clinically led, customer focused, scientifically driven pathology services while also recognising the partnership with KingsPath as a major milestone for the organisation, making it the largest independent pathology provider in the UK.

This year's HealthInvestor Awards saw an increase in the number of submissions of more than 40%, making it one of the most competetive years ever.

The awards ceremony will take place on Thursday 2 June, 2011.